XML 61 R50.htm IDEA: XBRL DOCUMENT v3.19.2
Fair value measurements Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2017
Derivative Financial Instruments, Liabilities [Member] | Level 3                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Balance - Beginning of Period, Liabilities   $ 2   $ 2        
Transfers into level 3, liability   0   0        
Transfers out of Level 3, Liabilities   0   0        
Change in Net Unrealized Gains (Losses) included in OCI, Liabilities   0   0        
Net Realized Gains/Losses, Liabilities   0   0        
Purchases, Liabilities   0   0        
Sales, Liabilities   0   0        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements   0   0        
Balance - End of Period, Liabilities   2   2        
Fair Value, Liabilities Measured on Recurring Basis, Change in Unrealized Gain (Loss)   0   0        
Guaranteed Minimum Income Benefit [Member]                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Reported liabilities $ 815 497 $ 815 497 $ 741 $ 861 $ 529 $ 550
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Balance - Beginning of Period, Liabilities 338 167 452 204        
Balance - End of Period, Liabilities 403 125 403 125        
Guaranteed Minimum Income Benefit [Member] | Guarantees [Member] | Level 3                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Balance - Beginning of Period, Liabilities 338 [1] 167 [2] 452 [3] 204 [4]        
Transfers into level 3, liability 0 0 0 0        
Transfers out of Level 3, Liabilities 0 0 0 0        
Change in Net Unrealized Gains (Losses) included in OCI, Liabilities 0 0 0 0        
Net Realized Gains/Losses, Liabilities 65 (42) (49) (79)        
Purchases, Liabilities 0 0 0 0        
Sales, Liabilities 0 0 0 0        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 0 0 0 0        
Balance - End of Period, Liabilities 403 [1],[3] 125 [2],[4] 403 [1],[3] 125 [2],[4]        
Fair Value, Liabilities Measured on Recurring Basis, Change in Unrealized Gain (Loss) $ 65 $ (42) $ (49) $ (79)        
[1] Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $815 million at June 30, 2019, and $741 million at March 31, 2019, which includes a fair value derivative adjustment of $403 million and $338 million, respectively
[2]
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $529 million at March 31, 2018, which includes a fair value derivative adjustment of $125 million and $167 million, respectively.
[3]
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $815 million at June 30, 2019, and $861 million at December 31, 2018, which includes a fair value derivative adjustment of $403 million and $452 million, respectively.
[4]
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $550 million at December 31, 2017, which includes a fair value derivative adjustment of $125 million and $204 million, respectively.